Laprophan Overview

  • Year Founded
  • 1949

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 1,450

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Financing Rounds
  • 2

  • Investments
  • 6

Laprophan General Information

Description

Manufacturer of pharmaceutical products intended to provide innovative and accessible healthcare solutions. The company operates a dedicated research and development center, holds multiple international patents, and manages integrated industrial operations, providing antibiotics, cardiovascular medications, neuropsychiatry treatments, anesthetics, digestive medicines, respiratory treatments, massive solutes, and vitamin supplements, enabling healthcare professionals and patients to access high-quality therapeutic treatments across major medical fields.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Corporate Office
  • 18 Boulevard Emile Zola
  • Casablanca, 20300
  • Morocco
+212
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 18 Boulevard Emile Zola
  • Casablanca, 20300
  • Morocco
+212

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Laprophan Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laprophan‘s full profile, request access.

Request a free trial

Laprophan Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended to provide innovative and accessible healthcare solutions. The company
Pharmaceuticals
Casablanca, Morocco
1,450 As of 2026

Sao Paulo, Brazil

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Laprophan Competitors (22)

One of Laprophan’s 22 competitors is Glenmark Farmacêutica, a Corporation company based in Sao Paulo, Brazil.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glenmark Farmacêutica Corporation Sao Paulo, Brazil
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India
Glenmark Pharmaceuticals Corporation Mumbai, India
Macleods Pharmaceuticals Corporation Mumbai, India
Celon Labs Formerly VC-backed Hyderabad, India
You’re viewing 5 of 22 competitors. Get the full list »

Laprophan Patents

Laprophan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2678042-A1 Pharmaceutical composition containing phloroglucinol and paracetamol Active 19-Feb-2007
CA-2678042-C Pharmaceutical composition containing phloroglucinol and paracetamol Active 19-Feb-2007
US-20100168238-A1 Pharmaceutical composition containing phloroglucinol and paracetamol Active 19-Feb-2007
US-8148425-B2 Pharmaceutical composition containing phloroglucinol and paracetamol Active 19-Feb-2007
AU-2002237368-A1 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies Inactive 09-Feb-2001
To view Laprophan’s complete patent history, request access »

Laprophan Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Laprophan Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Laprophan‘s full profile, request access.

Request a free trial

Laprophan Investments (6)

Laprophan’s most recent deal was a Buyout/LBO with Corporate Investment Holding. The deal was made on 20-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Corporate Investment Holding 20-Oct-2026 Buyout/LBO Holding Companies
Pian Holding 05-Feb-2026 Buyout/LBO Holding Companies
Double-e Pharma 23-Oct-2025 Buyout/LBO Consulting Services (B2B)
Rivopharm 29-Sep-2025 Buyout/LBO Pharmaceuticals
Botanic Pharma 25-Jun-2024 Buyout/LBO Pharmaceuticals
You’re viewing 5 of 6 investments. Get the full list »

Laprophan Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Botanic Pharma Casablanca, Morocco 2012
Amanys Pharma Ain El Aouda, Morocco 2011
Rivopharm Manno, Switzerland 1961

Laprophan FAQs

  • When was Laprophan founded?

    Laprophan was founded in 1949.

  • Where is Laprophan headquartered?

    Laprophan is headquartered in Casablanca, Morocco.

  • What is the size of Laprophan?

    Laprophan has 1,450 total employees.

  • What industry is Laprophan in?

    Laprophan’s primary industry is Pharmaceuticals.

  • Is Laprophan a private or public company?

    Laprophan is a Private company.

  • What is Laprophan’s current revenue?

    The current revenue for Laprophan is .

  • How much funding has Laprophan raised over time?

    Laprophan has raised $72.2M.

  • Who are Laprophan’s investors?

    DEG, FMO Entrepreneurial Development Bank, and Mediterrania Capital Partners have invested in Laprophan.

  • Who are Laprophan’s competitors?

    Glenmark Farmacêutica, Intas Pharmaceuticals, Glenmark Pharmaceuticals, Macleods Pharmaceuticals, and Celon Labs are some of the 22 competitors of Laprophan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process